Any therapeutic substance obtained from human blood, including whole blood and other blood components for transfusion, as well as plasma-derived pharmaceutical compounds, is referred to as a blood product. Medicinal (medical therapeutic) products obtained from human blood and plasma donations play an important role in medical care. Every year, blood products that are safe, effective, and of high-quality help to improve and save millions of lives. Inadequate or unsafe blood supplies have a detrimental influence on the ability of critical health services and programmes to offer proper patient care in a variety of acute and chronic illnesses. Access to safe, effective, and quality-assured blood products for all patients who require transfusion is a critical component of a functional health system and essential for patient safety.
Title : Overview of 2021 guidelines on the diagnosis of Von Willebrand Disease (VWD)
Maryam Asif, University of Washington, United States
Title : Clonal evolution in children with inherited bone marrow failure syndromes
Raykina Elena, Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology, Russian Federation
Title : Defining the clinical contribution of platelet-derived FXIII-A to regulation of fibrinolysis
Fahad S Alshehri, King Faisal Medical City for Southern Region, Saudi Arabia
Title : Prevalence of thalassemia and hemoglobinopathy in eastern India A 10-year high-performance liquid chromatography study of 119,336 cases
Santosh Kumar Mondal, Department of Pathology and Laboratory Medicine AIIMS, India
Title : Age-dependent trends in the expression of major haemoglobin types among infants of African descent in the first twenty-four months of life
Zaccheaus Awortu Jeremiah, Rivers State University, Nigeria
Title : Clinical case of thrombotic thrombocytopenia purpura
Nguyen Dang Duc, Bach Mai Hospital, Vietnam